ClariVest Asset Management’s iRadimed IRMD Stock Holding History

ClariVest Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$776K	Hold	17,666	–	–	0.08%	300
2024 Q2	$776K	Buy	17,666 +494	+3%	+$21K	0.08%	300
2024 Q1	$755K	Buy	17,172 +6	+0%	+$265	0.08%	311
2023 Q4	$815K	Buy	17,166 +397	+2%	+$16.7K	0.05%	294
2023 Q3	$744K	Hold	16,769	–	–	0.04%	291
2023 Q2	$800K	Buy	16,769 +2,981	+22%	+$134K	0.04%	287
2023 Q1	$542K	Sell	13,788 -34	-0.2%	-$1.24K	0.02%	374
2022 Q4	$391K	Sell	13,822 -200	-1%	-$5.72K	0.02%	400
2022 Q3	$422K	Hold	14,022	–	–	0.02%	382
2022 Q2	$476K	Buy	14,022 +3,700	+36%	+$133K	0.02%	384
2022 Q1	$463K	Buy	10,322 +10,300	+46,818%	+$476K	0.02%	400
2021 Q4	$1K	Hold	22	–	–	﹤0.01%	699
2021 Q3	$1K	Buy	+22	New	+$748	﹤0.01%	696

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClariVest Asset Management's IRMD Position: Q3 2024 in Review

ClariVest Asset Management held its iRadimed (IRMD) position steady in Q3 2024 at 17,666 shares worth $776K. The position accounts for 0.08% of the portfolio, ranked #300.

ClariVest Asset Management first reported a position in IRMD in Q3 2021 and has held it in 13 quarters since. The position peaked at $815K in Q4 2023. 145 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

ClariVest Asset Management held 17,666 shares of iRadimed worth $776K as of Q3 2024.
ClariVest Asset Management left its iRadimed share count unchanged in Q3 2024.
iRadimed made up 0.08% of ClariVest Asset Management's portfolio in Q3 2024, its #300 holding.
ClariVest Asset Management first reported a position in iRadimed in Q3 2021 and has held it in 13 quarters since.
ClariVest Asset Management's iRadimed position peaked at $815K in Q4 2023.
145 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.